The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
 
Carlo Buonerba
Consulting or Advisory Role - Sanofi
Research Funding - Astellas Pharma (Inst); Quercegen Pharmaceuticals (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Amgen; Argos Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options/NCCN
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Onyx (Inst)
Other Relationship - Boehringer Ingelheim
 
Gregory Russell Pond
No Relationships to Disclose
 
Martina Pagliuca
No Relationships to Disclose
 
Sabrina Rossetti
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Sarah Scagliarini
No Relationships to Disclose
 
Bruno Daniele
No Relationships to Disclose
 
Piera Federico
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Giacomo Cartenì
No Relationships to Disclose
 
Matteo Ferro
No Relationships to Disclose
 
Giuseppe Lucarelli
No Relationships to Disclose
 
Teresa Bellelli
No Relationships to Disclose
 
Sabino De Placido
No Relationships to Disclose
 
Giuseppe di Lorenzo
Honoraria - Sanofi
Consulting or Advisory Role - Ipsen
Research Funding - Astellas Pharma (Inst); Quercegen Pharmaceuticals (Inst); Sanofi (Inst)